Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain
Huijing Wang(Shanghai University), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)
Cited by 97
Related Papers
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
|Nature Medicine|2023|372
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
|Patient Preference and Adherence|2018|111
GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
|Journal of Neuroscience|2010|106
CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain
|JCI Insight|2022|93